Biopharma doubles down on immunology and inflammation as companies target new pathways and seek to improve on current options ...

Sanofi (NASDAQ:SNY – Free Report) by 25.6% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 314,180 shares of the company’s stock ...

Arcutis Biotherapeutics has a lofty goal for 2025 — and it could help Arcutis stock continue a massive run that helped shares quadruple last year.

We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc.

This gradual shift has raised concerns about the franchise's ability to withstand competitive pressures in the near term. Dupixent has emerged as a significant growth driver for Regeneron, showing ...

with peanut allergy in the U.S. and Canada to determine the impact of subcutaneous dupilumab (Dupixent; Sanofi, Regeneron) given every 2 weeks on desensitization to peanut exposure by the 24-week ...

At launch, the Flexus Core 200 sat at the top of Klipsch’s soundbar range, though a step-up model has since been announced. It’s off to a solid start, especially from a specification perspective. The ...

By Keith Caulfield Bad Bunny’s Debí Tirar Más Fotos captures a second week at No. 1 on the Billboard 200 albums chart (dated Feb. 1), earning 151,000 equivalent album units in the U.S. in the ...

In September 2024, the US Food and Drug Administration (FDA) approved Dupixent as an add-on maintenance treatment for adults with inadequately controlled chronic obstructive pulmonary disease ...

Update: Sony has gone some way towards addressing the main issue with its first-generation 70-200mm f/2.8 lens in the form of its successor: the FE 70-200 f/2.8 GM II. This updated version is a full ...